25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

524518 (Krebs Biochemicals & Industries Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze Krebs Biochemicals & Industries Limited together

I guess you are interested in Krebs Biochemicals & Industries Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Krebs Biochemicals & Industries Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Krebs Biochemicals & Industries Limited’s Price Targets

I'm going to help you getting a better view of Krebs Biochemicals & Industries Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Krebs Biochemicals & Industries Limited

I send you an email if I find something interesting about Krebs Biochemicals & Industries Limited.

1. Quick Overview

1.1. Quick analysis of Krebs Biochemicals & Industries Limited (30 sec.)










1.2. What can you expect buying and holding a share of Krebs Biochemicals & Industries Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
INR-55.30
Expected worth in 1 year
INR-91.95
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
INR-36.65
Return On Investment
-48.9%

For what price can you sell your share?

Current Price per Share
INR75.00
Expected price per share
INR63.55 - INR80.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Krebs Biochemicals & Industries Limited (5 min.)




Live pricePrice per Share (EOD)
INR75.00
Intrinsic Value Per Share
INR-201.18 - INR136.54
Total Value Per Share
INR-256.47 - INR81.25

2.2. Growth of Krebs Biochemicals & Industries Limited (5 min.)




Is Krebs Biochemicals & Industries Limited growing?

Current yearPrevious yearGrowGrow %
How rich?-$13.5m-$11.3m-$2.2m-16.6%

How much money is Krebs Biochemicals & Industries Limited making?

Current yearPrevious yearGrowGrow %
Making money-$2.2m-$2.8m$565.8k25.2%
Net Profit Margin-39.1%-47.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Krebs Biochemicals & Industries Limited (5 min.)




2.4. Comparing to competitors in the Other industry (5 min.)




  Industry Rankings (Other)  


Richest
#368 / 382

Most Revenue
#330 / 382

Most Profit
#335 / 382

Most Efficient
#363 / 382
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Krebs Biochemicals & Industries Limited?

Welcome investor! Krebs Biochemicals & Industries Limited's management wants to use your money to grow the business. In return you get a share of Krebs Biochemicals & Industries Limited.

First you should know what it really means to hold a share of Krebs Biochemicals & Industries Limited. And how you can make/lose money.

Speculation

The Price per Share of Krebs Biochemicals & Industries Limited is INR75.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Krebs Biochemicals & Industries Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Krebs Biochemicals & Industries Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR-55.30. Based on the TTM, the Book Value Change Per Share is INR-9.16 per quarter. Based on the YOY, the Book Value Change Per Share is INR-11.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Krebs Biochemicals & Industries Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.10-0.1%-0.10-0.1%-0.13-0.2%-0.16-0.2%-0.16-0.2%-0.12-0.2%
Usd Book Value Change Per Share-0.10-0.1%-0.10-0.1%-0.13-0.2%-0.13-0.2%-0.11-0.1%-0.07-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.10-0.1%-0.10-0.1%-0.13-0.2%-0.13-0.2%-0.11-0.1%-0.07-0.1%
Usd Price Per Share0.70-0.70-0.64-0.99-0.98-1.15-
Price to Earnings Ratio-6.67--6.67--4.92--6.18--6.05--11.36-
Price-to-Total Gains Ratio-6.66--6.66--4.99--7.55--9.50--4.33-
Price to Book Ratio-1.10--1.10--1.22--2.15--3.39-10.74-
Price-to-Total Gains Ratio-6.66--6.66--4.99--7.55--9.50--4.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.855
Number of shares1169
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.10-0.11
Usd Total Gains Per Share-0.10-0.11
Gains per Quarter (1169 shares)-122.11-127.97
Gains per Year (1169 shares)-488.42-511.88
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-488-4980-512-522
20-977-9860-1024-1034
30-1465-14740-1536-1546
40-1954-19620-2048-2058
50-2442-24500-2559-2570
60-2931-29380-3071-3082
70-3419-34260-3583-3594
80-3907-39140-4095-4106
90-4396-44020-4607-4618
100-4884-48900-5119-5130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%3.08.00.027.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.011.00.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%3.08.00.027.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Krebs Biochemicals & Industries Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---9.163-9.1630%-11.304+23%-11.172+22%-9.603+5%-5.713-38%
Book Value Per Share---55.295-55.2950%-46.133-17%-45.419-18%-34.155-38%-17.042-69%
Current Ratio--0.2820.2820%0.327-14%0.355-20%0.389-28%0.414-32%
Debt To Asset Ratio--1.6691.6690%1.568+6%1.544+8%1.418+18%1.204+39%
Debt To Equity Ratio----0%-0%-0%-0%9.454-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value---1657631800.000-1657631800.0000%-1528282000.000-8%-914263731.333-45%-598716748.800-64%231094966.218-817%
Eps---9.150-9.1500%-11.453+25%-13.752+50%-14.085+54%-10.926+19%
Ev To Sales Ratio---3.288-3.2880%-2.931-11%-1.826-44%-1.184-64%762.817-100%
Free Cash Flow Per Share---3.298-3.2980%-18.493+461%-14.112+328%-17.095+418%-14.008+325%
Free Cash Flow To Equity Per Share---0.717-0.7170%-1.172+63%-1.370+91%-2.781+288%-1.260+76%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--136.542----------
Intrinsic Value_10Y_min---201.179----------
Intrinsic Value_1Y_max---8.056----------
Intrinsic Value_1Y_min---18.051----------
Intrinsic Value_3Y_max---7.638----------
Intrinsic Value_3Y_min---56.383----------
Intrinsic Value_5Y_max--12.754----------
Intrinsic Value_5Y_min---96.776----------
Market Cap1471545000.000+11%1315591200.0001315591200.0000%1215984000.000+8%1874454602.000-30%1794716251.200-27%2023973566.218-35%
Net Profit Margin---0.391-0.3910%-0.474+21%-0.537+37%-0.601+53%-55.564+14101%
Operating Margin----0%-0%-0%-0.1090%-43.4200%
Operating Ratio--0.5670.5670%0.776-27%0.827-31%1.117-49%53.049-99%
Pb Ratio-1.356-23%-1.104-1.1040%-1.223+11%-2.148+95%-3.390+207%10.744-110%
Pe Ratio-8.196-23%-6.669-6.6690%-4.925-26%-6.179-7%-6.050-9%-11.365+70%
Price Per Share75.000+19%61.02061.0200%56.400+8%86.940-30%86.314-29%100.577-39%
Price To Free Cash Flow Ratio-22.740-23%-18.501-18.5010%-3.050-84%-9.510-49%-7.297-61%-60.059+225%
Price To Total Gains Ratio-8.186-23%-6.660-6.6600%-4.989-25%-7.546+13%-9.495+43%-4.326-35%
Quick Ratio--0.0800.0800%0.016+390%0.037+120%0.027+199%0.085-6%
Return On Assets---0.111-0.1110%-0.141+27%-0.162+46%-0.176+59%-0.149+35%
Return On Equity----0%-0%-0%-0%-1.2450%
Total Gains Per Share---9.163-9.1630%-11.304+23%-11.172+22%-9.603+5%-5.713-38%
Usd Book Value---13590703.800-13590703.8000%-11338702.200-17%-11163343.600-18%-8242222.800-39%-4113139.380-70%
Usd Book Value Change Per Share---0.104-0.1040%-0.129+23%-0.127+22%-0.109+5%-0.065-38%
Usd Book Value Per Share---0.630-0.6300%-0.526-17%-0.518-18%-0.389-38%-0.194-69%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value---18897002.520-18897002.5200%-17422414.800-8%-10422606.537-45%-6825370.936-64%2634482.615-817%
Usd Eps---0.104-0.1040%-0.131+25%-0.157+50%-0.161+54%-0.125+19%
Usd Free Cash Flow---810631.200-810631.2000%-4545294.000+461%-3468499.400+328%-4010982.840+395%-3226772.280+298%
Usd Free Cash Flow Per Share---0.038-0.0380%-0.211+461%-0.161+328%-0.195+418%-0.160+325%
Usd Free Cash Flow To Equity Per Share---0.008-0.0080%-0.013+63%-0.016+91%-0.032+288%-0.014+76%
Usd Market Cap16775613.000+11%14997739.68014997739.6800%13862217.600+8%21368782.463-30%20459765.264-27%23073298.655-35%
Usd Price Per Share0.855+19%0.6960.6960%0.643+8%0.991-30%0.984-29%1.147-39%
Usd Profit---2249037.600-2249037.6000%-2814876.600+25%-3379989.800+50%-3332851.560+48%-2535155.940+13%
Usd Revenue--5748051.0005748051.0000%5943321.600-3%6165842.000-7%5685670.200+1%3828799.440+50%
Usd Total Gains Per Share---0.104-0.1040%-0.129+23%-0.127+22%-0.109+5%-0.065-38%
 EOD+6 -2MRQTTM+0 -0YOY+21 -123Y+20 -135Y+21 -1210Y+15 -19

3.3 Fundamental Score

Let's check the fundamental score of Krebs Biochemicals & Industries Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.196
Price to Book Ratio (EOD)Between0-1-1.356
Net Profit Margin (MRQ)Greater than0-0.391
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.080
Current Ratio (MRQ)Greater than10.282
Debt to Asset Ratio (MRQ)Less than11.669
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.111
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Krebs Biochemicals & Industries Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose76.750
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Krebs Biochemicals & Industries Limited

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was founded in 1991 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2025-09-09 12:40:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Krebs Biochemicals & Industries Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • A Net Profit Margin of -39.1%Β means thatΒ ₹-0.39 for each ₹1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is -39.1%. The company is making a huge loss. -2
  • The TTM is -39.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-39.1%TTM-39.1%0.0%
TTM-39.1%YOY-47.4%+8.2%
TTM-39.1%5Y-60.1%+20.9%
5Y-60.1%10Y-5,556.4%+5,496.3%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-39.1%6.5%-45.6%
TTM-39.1%5.8%-44.9%
YOY-47.4%5.7%-53.1%
3Y-53.7%6.0%-59.7%
5Y-60.1%5.9%-66.0%
10Y-5,556.4%5.7%-5,562.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Krebs Biochemicals & Industries Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • -11.1% Return on Assets means thatΒ Krebs Biochemicals & Industries Limited generatedΒ ₹-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is -11.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.1%TTM-11.1%0.0%
TTM-11.1%YOY-14.1%+3.0%
TTM-11.1%5Y-17.6%+6.5%
5Y-17.6%10Y-14.9%-2.7%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.1%1.4%-12.5%
TTM-11.1%1.2%-12.3%
YOY-14.1%1.1%-15.2%
3Y-16.2%1.1%-17.3%
5Y-17.6%1.3%-18.9%
10Y-14.9%1.3%-16.2%
4.3.1.3. Return on Equity

Shows how efficient Krebs Biochemicals & Industries Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • 0.0% Return on Equity means Krebs Biochemicals & Industries Limited generated ₹0.00Β for eachΒ ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-124.5%+124.5%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.8%-3.8%
TTM-3.6%-3.6%
YOY-3.4%-3.4%
3Y-3.4%-3.4%
5Y-3.7%-3.7%
10Y-124.5%3.7%-128.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Krebs Biochemicals & Industries Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Krebs Biochemicals & Industries Limited is operatingΒ .

  • Measures how much profit Krebs Biochemicals & Industries Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • An Operating Margin of 0.0%Β means the company generated ₹0.00 Β for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-10.9%+10.9%
5Y-10.9%10Y-4,342.0%+4,331.1%
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-9.7%
TTM-8.2%-8.2%
YOY-3.0%-3.0%
3Y-2.3%-2.3%
5Y-10.9%1.9%-12.8%
10Y-4,342.0%5.8%-4,347.8%
4.3.2.2. Operating Ratio

Measures how efficient Krebs Biochemicals & Industries Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Other industry mean).
  • An Operation Ratio of 0.57 means that the operating costs are ₹0.57 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 0.567. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.567. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.567TTM0.5670.000
TTM0.567YOY0.776-0.209
TTM0.5675Y1.117-0.550
5Y1.11710Y53.049-51.931
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5671.224-0.657
TTM0.5671.210-0.643
YOY0.7761.283-0.507
3Y0.8271.262-0.435
5Y1.1171.248-0.131
10Y53.0491.288+51.761
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Krebs Biochemicals & Industries Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Krebs Biochemicals & Industries Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Other industry mean).
  • A Current Ratio of 0.28Β means the company has ₹0.28 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 0.282. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.282. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.282TTM0.2820.000
TTM0.282YOY0.327-0.045
TTM0.2825Y0.389-0.107
5Y0.38910Y0.414-0.025
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2821.394-1.112
TTM0.2821.402-1.120
YOY0.3271.444-1.117
3Y0.3551.506-1.151
5Y0.3891.553-1.164
10Y0.4141.508-1.094
4.4.3.2. Quick Ratio

Measures if Krebs Biochemicals & Industries Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • A Quick Ratio of 0.08Β means the company can pay off ₹0.08 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 0.080. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.080. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.0800.000
TTM0.080YOY0.016+0.064
TTM0.0805Y0.027+0.053
5Y0.02710Y0.085-0.058
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.574-0.494
TTM0.0800.563-0.483
YOY0.0160.597-0.581
3Y0.0370.595-0.558
5Y0.0270.615-0.588
10Y0.0850.608-0.523
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Krebs Biochemicals & Industries Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Krebs Biochemicals & Industries LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Krebs Biochemicals & Industries Limited to Other industry mean.
  • A Debt to Asset Ratio of 1.67Β means that Krebs Biochemicals & Industries Limited assets areΒ financed with 166.9% credit (debt) and the remaining percentage (100% - 166.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 1.669. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.669. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.669TTM1.6690.000
TTM1.669YOY1.568+0.101
TTM1.6695Y1.418+0.251
5Y1.41810Y1.204+0.214
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6690.517+1.152
TTM1.6690.519+1.150
YOY1.5680.528+1.040
3Y1.5440.533+1.011
5Y1.4180.544+0.874
10Y1.2040.549+0.655
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Krebs Biochemicals & Industries Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • A Debt to Equity ratio of 0.0% means that company has ₹0.00 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Krebs Biochemicals & Industries Limited:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y9.454-9.454
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.038-1.038
TTM-1.038-1.038
YOY-1.114-1.114
3Y-1.153-1.153
5Y-1.225-1.225
10Y9.4541.303+8.151
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every ₹1 in earnings Krebs Biochemicals & Industries Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ Krebs Biochemicals & Industries Limited to theΒ Other industry mean.
  • A PE ratio of -6.67 means the investor is paying ₹-6.67Β for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Krebs Biochemicals & Industries Limited:

  • The EOD is -8.196. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.669. Based on the earnings, the company is expensive. -2
  • The TTM is -6.669. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.196MRQ-6.669-1.528
MRQ-6.669TTM-6.6690.000
TTM-6.669YOY-4.925-1.744
TTM-6.6695Y-6.050-0.619
5Y-6.05010Y-11.365+5.315
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-8.19616.583-24.779
MRQ-6.66915.941-22.610
TTM-6.66915.198-21.867
YOY-4.92513.618-18.543
3Y-6.17911.917-18.096
5Y-6.05014.717-20.767
10Y-11.36514.549-25.914
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Krebs Biochemicals & Industries Limited:

  • The EOD is -22.740. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.501. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.501. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-22.740MRQ-18.501-4.239
MRQ-18.501TTM-18.5010.000
TTM-18.501YOY-3.050-15.452
TTM-18.5015Y-7.297-11.204
5Y-7.29710Y-60.059+52.761
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-22.74010.307-33.047
MRQ-18.5019.068-27.569
TTM-18.5017.516-26.017
YOY-3.0506.379-9.429
3Y-9.5103.943-13.453
5Y-7.2973.925-11.222
10Y-60.0593.789-63.848
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Krebs Biochemicals & Industries Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Other industry mean).
  • A PB ratio of -1.10 means the investor is paying ₹-1.10Β for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Krebs Biochemicals & Industries Limited:

  • The EOD is -1.356. Based on the equity, the company is expensive. -2
  • The MRQ is -1.104. Based on the equity, the company is expensive. -2
  • The TTM is -1.104. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.356MRQ-1.104-0.253
MRQ-1.104TTM-1.1040.000
TTM-1.104YOY-1.223+0.119
TTM-1.1045Y-3.390+2.287
5Y-3.39010Y10.744-14.134
Compared to industry (Other)
PeriodCompanyIndustry (mean)+/- 
EOD-1.3561.737-3.093
MRQ-1.1041.600-2.704
TTM-1.1041.498-2.602
YOY-1.2231.494-2.717
3Y-2.1481.575-3.723
5Y-3.3901.899-5.289
10Y10.7441.819+8.925
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets1,781,747
Total Liabilities2,973,914
Total Stockholder Equity-1,192,167
 As reported
Total Liabilities 2,973,914
Total Stockholder Equity+ -1,192,167
Total Assets = 1,781,747

Assets

Total Assets1,781,747
Total Current Assets174,422
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 691
Net Receivables 48,945
Inventory 102,445
Other Current Assets 683
Total Current Assets  (as reported)174,422
Total Current Assets  (calculated)152,764
+/- 21,658
Long-term Assets
Property Plant Equipment 1,494,563
Intangible Assets 25,032
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,519,595
+/- 1,519,595

Liabilities & Shareholders' Equity

Total Current Liabilities618,339
Long-term Liabilities0
Total Stockholder Equity-1,192,167
Total Current Liabilities
Short-term Debt 99,295
Total Current Liabilities  (as reported)618,339
Total Current Liabilities  (calculated)99,295
+/- 519,044
Long-term Liabilities
Long term Debt Total 1,835,000
Capital Lease Obligations Min Short Term Debt-99,295
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)1,735,705
+/- 1,735,705
Total Stockholder Equity
Common Stock215,606
Retained Earnings -2,702,395
Capital Surplus 1,180,176
Other Stockholders Equity 114,446
Total Stockholder Equity (as reported)-1,192,167
Total Stockholder Equity (calculated)-1,192,167
+/-0
Other
Cash and Short Term Investments 691
Common Stock Shares Outstanding 21,560
Liabilities and Stockholders Equity 1,781,747
Net Working Capital -443,917



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
1,377,808
1,084,392
1,164,189
1,220,767
1,258,759
1,423,650
1,338,002
1,592,203
1,898,057
1,749,817
1,781,747
1,781,7471,749,8171,898,0571,592,2031,338,0021,423,6501,258,7591,220,7671,164,1891,084,3921,377,808
   > Total Current Assets 
388,099
148,677
93,895
131,882
172,386
309,767
188,599
214,176
354,933
160,609
174,422
174,422160,609354,933214,176188,599309,767172,386131,88293,895148,677388,099
       Cash And Cash Equivalents 
3,561
63,094
2,681
1,171
4,184
147,000
1,743
5,925
324
176
691
6911763245,9251,743147,0004,1841,1712,68163,0943,561
       Short-term Investments 
0
0
0
60,279
3,351
0
-1
0
0
-1
0
0-100-103,35160,279000
       Net Receivables 
46,265
19,425
278
15,883
3,248
29,109
2,021
2,998
9,734
7,874
48,945
48,9457,8749,7342,9982,02129,1093,24815,88327819,42546,265
       Inventory 
308,244
54,530
56,356
54,549
117,284
89,637
153,885
168,905
258,648
123,561
102,445
102,445123,561258,648168,905153,88589,637117,28454,54956,35654,530308,244
       Other Current Assets 
29,994
11,179
34,580
60,279
44,319
1,524
1,220
1,297
683
683
683
6836836831,2971,2201,52444,31960,27934,58011,17929,994
   > Long-term Assets 
0
0
0
1,088,885
1,086,373
1,113,883
1,149,403
0
0
0
0
00001,149,4031,113,8831,086,3731,088,885000
       Property Plant Equipment 
505,848
509,794
1,023,536
1,020,765
1,011,193
1,007,191
1,057,112
1,263,540
1,442,160
1,487,117
1,494,563
1,494,5631,487,1171,442,1601,263,5401,057,1121,007,1911,011,1931,020,7651,023,536509,794505,848
       Intangible Assets 
521
0
12,894
35,988
33,857
40,300
37,698
35,095
28,709
26,870
25,032
25,03226,87028,70935,09537,69840,30033,85735,98812,8940521
       Long-term Assets Other 
0
0
0
25,588
0
2
-2
0
0
0
0
0000-22025,588000
> Total Liabilities 
1,341,789
901,621
1,034,053
1,205,998
1,436,551
1,566,541
1,587,961
2,019,532
2,648,989
2,744,440
2,973,914
2,973,9142,744,4402,648,9892,019,5321,587,9611,566,5411,436,5511,205,9981,034,053901,6211,341,789
   > Total Current Liabilities 
1,098,437
287,245
295,245
317,162
449,797
548,615
431,335
481,924
780,640
491,047
618,339
618,339491,047780,640481,924431,335548,615449,797317,162295,245287,2451,098,437
       Short-term Debt 
931,386
609,128
305,690
475,474
0
0
0
0
99,862
99,904
99,295
99,29599,90499,8620000475,474305,690609,128931,386
       Short Long Term Debt 
931,386
609,128
305,690
475,474
45,491
31,505
7,068
0
0
0
0
00007,06831,50545,491475,474305,690609,128931,386
       Accounts payable 
191,016
158,014
118,807
105,403
166,806
186,426
200,300
0
0
0
0
0000200,300186,426166,806105,403118,807158,014191,016
       Other Current Liabilities 
59,420
10,568
32,313
43,916
36,702
83,009
86,818
0
0
0
0
000086,81883,00936,70243,91632,31310,56859,420
   > Long-term Liabilities 
0
0
0
888,836
986,754
1,017,926
1,156,626
0
0
0
0
00001,156,6261,017,926986,754888,836000
       Long term Debt Total 
0
0
253,096
427,874
516,617
502,271
655,058
1,005,464
1,329,300
1,732,465
1,835,000
1,835,0001,732,4651,329,3001,005,464655,058502,271516,617427,874253,09600
       Capital Lease Obligations 
0
0
0
0
356,701
407,348
450,000
0
0
0
0
0000450,000407,348356,7010000
       Other Liabilities 
20,159
38,286
485,712
460,962
497,119
515,655
501,568
0
0
0
0
0000501,568515,655497,119460,962485,71238,28620,159
> Total Stockholder Equity
36,019
182,771
130,136
14,769
-177,792
-142,891
-249,959
-427,329
-750,932
-994,623
-1,192,167
-1,192,167-994,623-750,932-427,329-249,959-142,891-177,79214,769130,136182,77136,019
   Common Stock
95,143
95,143
130,643
137,443
137,443
166,306
180,006
196,206
215,606
215,606
215,606
215,606215,606215,606196,206180,006166,306137,443137,443130,64395,14395,143
   Retained Earnings Total Equity00000000000
   Accumulated Other Comprehensive Income 00000000000
   Capital Surplus 
0
0
36,720
0
0
805,496
986,156
1,074,446
1,180,176
1,180,176
1,180,176
1,180,1761,180,1761,180,1761,074,446986,156805,4960036,72000
   Treasury Stock00000000000
   Other Stockholders Equity 
3,938
232,358
40,658
3,938
3,938
-106,632
114,446
114,446
114,446
114,446
114,446
114,446114,446114,446114,446114,446-106,6323,9383,93840,658232,3583,938



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue433,119
Cost of Revenue-55,557
Gross Profit377,562377,562
 
Operating Income (+$)
Gross Profit377,562
Operating Expense--
Operating Income-217,189377,562
 
Operating Expense (+$)
Research Development-
Selling General Administrative165,984
Selling And Marketing Expenses-
Operating Expense-165,984
 
Net Interest Income (+$)
Interest Income59,142
Interest Expense--
Other Finance Cost-59,142
Net Interest Income-
 
Pretax Income (+$)
Operating Income-217,189
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-269,240-217,189
EBIT - interestExpense = 0
-269,393
-269,393
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--269,240
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-269,240
Tax Provision-153
Net Income From Continuing Ops--269,393
Net Income-269,393
Net Income Applicable To Common Shares-269,393
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Krebs Biochemicals & Industries Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Krebs Biochemicals & Industries Limited. The general trend of Krebs Biochemicals & Industries Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Krebs Biochemicals & Industries Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Krebs Biochemicals & Industries Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Krebs Biochemicals & Industries Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 79.80 < 80.00 < 80.00.

The bearish price targets are: 70.50 > 70.50 > 63.55.

Know someone who trades $524518? Share this with them.πŸ‘‡

Krebs Biochemicals & Industries Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Krebs Biochemicals & Industries Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Krebs Biochemicals & Industries Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Moving Average Convergence/Divergence (MACD) ChartKrebs Biochemicals & Industries Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Krebs Biochemicals & Industries Limited. The current adx is .

Krebs Biochemicals & Industries Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Relative Strength Index (RSI) ChartKrebs Biochemicals & Industries Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Stochastic Oscillator ChartKrebs Biochemicals & Industries Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Commodity Channel Index (CCI) ChartKrebs Biochemicals & Industries Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Chande Momentum Oscillator (CMO) ChartKrebs Biochemicals & Industries Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Williams %R ChartKrebs Biochemicals & Industries Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Average True Range (ATR) ChartKrebs Biochemicals & Industries Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily On-Balance Volume (OBV) ChartKrebs Biochemicals & Industries Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Krebs Biochemicals & Industries Limited.

Krebs Biochemicals & Industries Limited Daily Money Flow Index (MFI) ChartKrebs Biochemicals & Industries Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Krebs Biochemicals & Industries Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-10RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-28BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-09-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Krebs Biochemicals & Industries Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Krebs Biochemicals & Industries Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose76.750
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Krebs Biochemicals & Industries Limited with someone you think should read this too:
  • Are you bullish or bearish on Krebs Biochemicals & Industries Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Krebs Biochemicals & Industries Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Krebs Biochemicals & Industries Limited

I send you an email if I find something interesting about Krebs Biochemicals & Industries Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Krebs Biochemicals & Industries Limited.

Receive notifications about Krebs Biochemicals & Industries Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.